During the EHA 2022 Congress, the MPN Hub was pleased to speak to Tiziano Barbui, Papa Giovanni XXIII Hospital, Bergamo, IT. We asked, Thrombotic events in MPN: What is the primary prophylaxis used to avoid the first arterial and venous events.
Barbui begins by talking about managing thrombotic risk, and how primary prophylaxis can affect the thrombotic risk. Barbui also discusses drugs used to manage thrombosis, including aspirin, interferons, hydroxyurea, and ruxolitinib.
